B. AKINCI And S. Yesil, "Role of thrombin activatable fibrinolysis inhibitor in endocrine and cardiovascular disorders," Recent Patents on Endocrine, Metabolic and Immune Drug Discovery , vol.2, no.1, pp.57-61, 2008
AKINCI, B. And Yesil, S. 2008. Role of thrombin activatable fibrinolysis inhibitor in endocrine and cardiovascular disorders. Recent Patents on Endocrine, Metabolic and Immune Drug Discovery , vol.2, no.1 , 57-61.
AKINCI, B., & Yesil, S., (2008). Role of thrombin activatable fibrinolysis inhibitor in endocrine and cardiovascular disorders. Recent Patents on Endocrine, Metabolic and Immune Drug Discovery , vol.2, no.1, 57-61.
AKINCI, BARIŞ, And Sena Yesil. "Role of thrombin activatable fibrinolysis inhibitor in endocrine and cardiovascular disorders," Recent Patents on Endocrine, Metabolic and Immune Drug Discovery , vol.2, no.1, 57-61, 2008
AKINCI, BARIŞ And Yesil, Sena. "Role of thrombin activatable fibrinolysis inhibitor in endocrine and cardiovascular disorders." Recent Patents on Endocrine, Metabolic and Immune Drug Discovery , vol.2, no.1, pp.57-61, 2008
AKINCI, B. And Yesil, S. (2008) . "Role of thrombin activatable fibrinolysis inhibitor in endocrine and cardiovascular disorders." Recent Patents on Endocrine, Metabolic and Immune Drug Discovery , vol.2, no.1, pp.57-61.
@article{article, author={BARIŞ AKINCI And author={Sena Yesil}, title={Role of thrombin activatable fibrinolysis inhibitor in endocrine and cardiovascular disorders}, journal={Recent Patents on Endocrine, Metabolic and Immune Drug Discovery}, year=2008, pages={57-61} }